Skip to main content

Table 5 Classes of other prescribed or used drugs reported by a subset of study participants who reported self-medication with cannabis in an online survey in Quebec from November 2020 to January 2021 (n = 247)

From: A description of self-medication with cannabis among adults with legal access to cannabis in Quebec, Canada

Likely indication Drug class Users (n = 247, 50.51%)
Pain Unspecified analgesic 36 (14.57)
Opioids 20 (8.10)
NSAID 46 (18.62)
Coanalgesic 17 (6.88)
Muscle relaxant 21 (8.50)
Anti-migraine 5 (2.02)
Corticosteroid 2 (0.81)
Intestinal anti-inflammatory drug (e.g., mesalamine) 2 (0.81)
Mood/anxiety/sleep disorder Antidepressant 84 (34.01)
Serotonin-norepinephrine reuptake inhibitor 4 (1.62)
Anxiolytic 30 (12.15)
Hypnotic (z-class or benzodiazepine) 34 (13.77)
Antipsychotic 27 (10.93)
Mood stabilizers 4 (1.62)
Attention deficit hyperactivity disorder Psychostimulant 27 (10.93)
Cardio-vascular/metabolic/digestive Antidiabetic 2 (0.81)
Antiacid 10 (4.05)
Antihypertensive 5 (2.02)
Anticoagulant 1 (0.40)
Beta-blocker 5 (2.02)
Asthma/smoking/allergies Antihistaminic 2 (0.81)
Nicotine replacement therapy 1 (0.40)
Inhaled corticosteroid 2 (0.81)
Others Oral contraceptive 2 (0.81)
Chemotherapy 1 (0.40)
Natural health product 9 (3.64)
Others 16 (6.48)
  1. Co-analgesics include gabapentinoid or tricyclic antidepressants
  2. NSAID Nonsteroidal anti-inflammatory drugs